… We found that MAP2, NSE and S100B were higher after COVID-19 indicative of brain injury
after COVID-19. MAP-2 is a dendritic injury marker that is elevated in both the acute and …

… COVID-19 patients develop a ‘post-COVID-19 syndrome’ defined as the persistence of a
wide spectrum of symptoms beyond four weeks after infection (2). In symptomatic COVID-19 …

… use of anticoagulant therapy in COVID-19 patients. In addition … blood markers is necessary
for management of COVID-19 … ferritin are observed in most COVID19 patients. The degree of …

… markers with disease severity and mortality in COVID-19 patients but their association with
cognitive function remains … inflammatory markers with cognitive function in COVID-19 patients. …

… Higher marker values may predispose patients with COVID-19 to have an unfavorable
prognosis. MR-proADM is the biomarker with the strongest discriminating power for longer-term (…

… coronavirus 2 (… markers such as C-reactive protein (CRP) and ferritin and changes
such as lymphocytopenia have been previously reported in coronavirus disease 2019 (COVID-19) …

… The fact that we had a higher number of obese patients in the COVID-19 group reinforces
our results, since the COVID-19 group was found to have lower PR compared to the control …

… Further research on the function of each factor is needed … markers for the development of
severe/critical COVID-19 were discovered by analyzing serial serum samples. The Cat-A marker…

… La información sobre el daño miocárdico en la población con COVID-19 es muy escasa.
Nuestro objetivo fue evaluar el daño cardiaco en pacientes con COVID-19 y determinar la …

… Function Tests in defining the severity of COVID-19 and possible need for intensive care. …
marker for predicting the severity of COVID-19. The positive correlation between COVID-19 …